Need Help? Call 1­-866-­796-­7386
« back to stock screener

  RGEN stock: Repligen Corporation

Current Rating
Hold/Sell

Previous Rating

Sell
Our Strong Buys
double the S&P500!
Learn more.
Company Statistics
Price
$170.33
Market Cap
9.68B
Sector
Health Care
Div. Growth
-
P/E
60.3
P/B
5.27
P/S
12.08
Dividend %
-
P/CF
-
P/FCF
157.4
Op. Cash Flow
159.8K
FCF
1.1
Op. Margin
26.60%
Net Margin
20.80%
ROE
9.30%
ROI
7.10%
ROA
6.90%
EPS Growth
38.00%
Current Ratio
2.5
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
HTG Molecular Diagnostics Inc (HTGM) $0.24 - - 5.3M Strong Buy
Cumberland Pharmaceuticals, In (CPIX) $2.18 - - 35.6M Strong Buy
RegeneRx Biopharmaceuticals In (RGRX) $0.16 - - 21.5M Strong Buy
Alimera Sciences Inc (ALIM) $3.24 - - 37.4M Strong Buy
Teva Pharmaceutical Industries (TEVA) $8.45 - - 9.63B Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More